United Therapeutics Corporation has grown revenue 17% a year over three years and 16% a year over five, with earnings per share compounding at 22%. Revenue growth, 3-year annual rate: +17% (Drug Manufacturers - Specialty & Generic median +15%). Revenue growth, 5-year rate: +16%, growth has picked up over the last three years. Earnings per share, 3-year rate: +22%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 18, FY2008 to FY2025, as filed.

UTHRUnited Therapeutics Corporation

HealthcareUSD

$516.77

$300.4352 weeks$596.76

Is it growing?

Is UTHR growing?

United Therapeutics Corporation has grown revenue 17% a year over three years and 16% a year over five, with earnings per share compounding at 22%.

+17%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +15% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +16%
Revenue growth, 5-year rate · +17% over three · growth has picked up over the last three years
Earnings per share, 3-year rate: +22%
Earnings per share, 3-year rate · revenue +17% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 18
Years of annual history on file · FY2008 to FY2025, as filed